REFERENCES

Akinfeeva, L.A., O.I. Aksionova, I.V. Vasilevich, Z.I. Gin’ko, K.A. Zar’kov, N.M. Zybavichene, L.R. Katkova, O.P. Kuzovlev, V.I. Kuzubov, L.I. Lokteva, and E.I. Ryabchikova. 2005. A case of Ebola hemorrhagic fever. Infektsionnye bolezni (Epidemiology and Infectious Diseases) 1:85-88.

Department of the Army. 2008. Nuclear and Chemical Weapons and Materiel: Biological Surety. Army Regulation 50-1. Headquarters, Department of the Army: Washington, D.C. 54 pp. [Online]. Available at: http://www.fas.org/irp/doddir/army/ar50-1.pdf.

Di, B., W. Hao, Y. Gao, M. Wang, Y.D. Wang, L.W. Qiu, K. Wen, D.H. Zhou, X.W. Wu, E.J. Lu, Z.Y. Liao, Y.B. Mei, B.J. Zheng, and X.Y. Che. 2005. Monoclonal antibody-based antigen capture enzyme-linked immunosorbent assay reveals high sensitivity of the nucleocapsid protein in acute-phase sera of severe acute respiratory syndrome patients. Clinical and Diagnostic Laboratory Immunology 12(1):135-140.

Ergonul, O. 2006. Crimean-Congo haemorrhagic fever. The Lancet Infectious Diseases 6(4):203-214.

Ergonul, O. 2008. Treatment of Crimean-Congo hemorrhagic fever. Antiviral Research 78(1):125-131.

Ergonul, O., H. Zeller, A. Celikbas, and B. Dokuzoguz. 2007. The lack of Crimean-Congo hemorrhagic fever virus antibodies in healthcare workers in an endemic region. International Journal of Infectious Diseases 11(1):48-51.

Federal Register. 2005. Galveston National Laboratory Record of Decision. 70(68):18408.

Franz, D.R. and J.W. Le Duc. 2011. Balancing our approach to the insider threat. Biosecurity and Bioterrorism: Biodefense Strategy, Practice, and Science 9(3):205-206.

Franz, D.R., S.A. Ehrlich, A. Casadevall, M.J. Imperiale, and P.S. Keim. 2009. The “nuclearization” of biology is a threat to health and security. Biosecurity and Bioterrorism: Biodefense Strategy, Practice, and Science 7(3):243-244.

Gaidamovich, S.Y., A.M. Butenko, and H.V. Leschinskaya. 2000. Human laboratory Acquired Arbo-, Arena- and Hantavirus infections. Journal of American Biological Safety Association 5(1):5-11.

Gaudioso, J., S.A. Caskey, L. Burnett, E. Heegaard, J. Owens, and P. Stroot. 2009. Strengthening Risk Governance in Bioscience Laboratories. Sandia Report: SAND2009-8070. Sandia National Laboratories. Albuquerque, NM. 147 pp.

Harding, A.L. and K.B. Byers. 2000. Epidemiology of laboratory-associated infection. In: Biological Safety: Principles and practices. Pp. 35-56. Fleming, D.O. and D.L. Hunt (Eds.). 3rd ed. Washington, D.C.: ASM Press.

Heckert, R.A., J.C. Reed, F. Gmuender, M. Ellis, and W. Tonui. 2011. International biosafety and biosecurity challenges: Suggestions for developing sustainable capacity in low-resource countries. Applied Biosafety 16(4).

Jackson, R.J., A.J. Ramsay, C.D. Christensen, S. Beaton, D.F. Hall, and I.A. Ramshaw. 2001. Expression of mouse interleukin-4 by a recombinant ectromelia virus suppresses cytolytic lymphocyte responses and overcomes genetic resistance to mousepox. The Journal of Virology 75(3):1205-1210.

Jefferson, T., R. Foxlee, C. Del Mar, L. Dooley, E. Ferroni, B. Hewak, A. Prabhala, S. Nair, and A. Rivetti. 2008. Physical interventions to interrupt or reduce the spread of respiratory viruses: Systematic review. British Medical Journal 336(7635):77-80.

Kaiser, J. 2011. Taking stock of the biodefense boom. Science 333(6047):1214.

Kruse, R.H., W.H. Puckett, and J.H. Richardson. 1991. Biological safety cabinetry. Clinical Microbiology Reviews 4(2):207-241.

Liu, X., Y. Shi, P. Li, L. Li, Y. Yi, Q. Ma, C. Cao. 2004. Profile of antibodies to the nucleocapsid protein of the severe acute respiratory syndrome (SARS)-associated coronavirus in probable SARS patients. Clinical and Diagnostic Laboratory Immunology 11(1):227-228.

Markotic, A., L. Hensley, T. Geisbert, K. Spik, and C. Schmaljohn. 2003. Hantaviruses induce cytopathic effects and apoptosis in continuous human embryonic kidney cells. Journal of General Virology 84(8):2197-2202.

Medina, R.A., B. Manicassamy, S. Stertz, C.W. Seibert, R. Hai, R.B. Belshe, S.E. Frey, C.F. Basler, P. Palese, and A. García-Sastre. 2010. Pandemic 2009 H1N1 vaccine protects against 1918 Spanish influenza virus. Nature Communications 1:28. doi: 10.1038/ncomms1026. Available at: http://www.nature.com/ncomms/journal/v1/n3/full/ncomms1026.html.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement



Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 97
REFERENCES Akinfeeva, L.A., O.I. Aksionova, I.V. Vasilevich, Z.I. Gin'ko, K.A. Zar'kov, N.M. Zybavichene, L.R. Katkova, O.P. Kuzovlev, V.I. Kuzubov, L.I. Lokteva, and E.I. Ryabchikova. 2005. A case of Ebola hemorrhagic fever. Infektsionnye bolezni (Epidemiology and Infectious Diseases) 1:85-88. Department of the Army. 2008. Nuclear and Chemical Weapons and Materiel: Biological Surety. Army Regulation 50-1. Headquarters, Department of the Army: Washington, D.C. 54 pp. [Online]. Available at: http://www.fas.org/irp/doddir/army/ar50-1.pdf. Di, B., W. Hao, Y. Gao, M. Wang, Y.D. Wang, L.W. Qiu, K. Wen, D.H. Zhou, X.W. Wu, E.J. Lu, Z.Y. Liao, Y.B. Mei, B.J. Zheng, and X.Y. Che. 2005. Monoclonal antibody-based antigen capture enzyme- linked immunosorbent assay reveals high sensitivity of the nucleocapsid protein in acute-phase sera of severe acute respiratory syndrome patients. Clinical and Diagnostic Laboratory Immunology 12(1):135-140. Ergonul, O. 2006. Crimean-Congo haemorrhagic fever. The Lancet Infectious Diseases 6(4):203-214. Ergonul, O. 2008. Treatment of Crimean-Congo hemorrhagic fever. Antiviral Research 78(1):125-131. Ergonul, O., H. Zeller, A. Celikbas, and B. Dokuzoguz. 2007. The lack of Crimean-Congo hemorrhagic fever virus antibodies in healthcare workers in an endemic region. International Journal of Infectious Diseases 11(1):48-51. Federal Register. 2005. Galveston National Laboratory Record of Decision. 70(68):18408. Franz, D.R. and J.W. Le Duc. 2011. Balancing our approach to the insider threat. Biosecurity and Bioterrorism: Biodefense Strategy, Practice, and Science 9(3):205-206. Franz, D.R., S.A. Ehrlich, A. Casadevall, M.J. Imperiale, and P.S. Keim. 2009. The “nuclearization” of biology is a threat to health and security. Biosecurity and Bioterrorism: Biodefense Strategy, Practice, and Science 7(3):243-244. Gaidamovich, S.Y., A.M. Butenko, and H.V. Leschinskaya. 2000. Human laboratory Acquired Arbo-, Arena- and Hantavirus infections. Journal of American Biological Safety Association 5(1):5-11. Gaudioso, J., S.A. Caskey, L. Burnett, E. Heegaard, J. Owens, and P. Stroot. 2009. Strengthening Risk Governance in Bioscience Laboratories. Sandia Report: SAND2009-8070. Sandia National Laboratories. Albuquerque, NM. 147 pp. Harding, A.L. and K.B. Byers. 2000. Epidemiology of laboratory-associated infection. In: Biological Safety: Principles and practices. Pp. 35-56. Fleming, D.O. and D.L. Hunt (Eds.). 3rd ed. Washington, D.C.: ASM Press. Heckert, R.A., J.C. Reed, F. Gmuender, M. Ellis, and W. Tonui. 2011. International biosafety and biosecurity challenges: Suggestions for developing sustainable capacity in low-resource countries. Applied Biosafety 16(4). Jackson, R.J., A.J. Ramsay, C.D. Christensen, S. Beaton, D.F. Hall, and I.A. Ramshaw. 2001. Expression of mouse interleukin-4 by a recombinant ectromelia virus suppresses cytolytic lymphocyte responses and overcomes genetic resistance to mousepox. The Journal of Virology 75(3):1205-1210. Jefferson, T., R. Foxlee, C. Del Mar, L. Dooley, E. Ferroni, B. Hewak, A. Prabhala, S. Nair, and A. Rivetti. 2008. Physical interventions to interrupt or reduce the spread of respiratory viruses: Systematic review. British Medical Journal 336(7635):77-80. Kaiser, J. 2011. Taking stock of the biodefense boom. Science 333(6047):1214. Kruse, R.H., W.H. Puckett, and J.H. Richardson. 1991. Biological safety cabinetry. Clinical Microbiology Reviews 4(2):207-241. Liu, X., Y. Shi, P. Li, L. Li, Y. Yi, Q. Ma, C. Cao. 2004. Profile of antibodies to the nucleocapsid protein of the severe acute respiratory syndrome (SARS)-associated coronavirus in probable SARS patients. Clinical and Diagnostic Laboratory Immunology 11(1):227-228. Markotic, A., L. Hensley, T. Geisbert, K. Spik, and C. Schmaljohn. 2003. Hantaviruses induce cytopathic effects and apoptosis in continuous human embryonic kidney cells. Journal of General Virology 84(8):2197-2202. Medina, R.A., B. Manicassamy, S. Stertz, C.W. Seibert, R. Hai, R.B. Belshe, S.E. Frey, C.F. Basler, P. Palese, and A. García-Sastre. 2010. Pandemic 2009 H1N1 vaccine protects against 1918 Spanish influenza virus. Nature Communications 1:28. doi: 10.1038/ncomms1026. Available at: http://www.nature.com/ncomms/journal/v1/n3/full/ncomms1026.html. 97

OCR for page 97
98 Biosecurity Challenges National Research Council (NRC). 2007a. The Biological Threat Reduction Program of the Department of Defense: From Foreign Assistance to Sustainable Partnerships. Washington, D.C.: National Academies Press. National Research Council. 2007b. Technical Input on the National Institutes of Health's Draft Supplementary Risk Assessments and Site Suitability Analyses for the National Emerging Infectious Diseases Laboratory, Boston University: A Letter Report. Washington, D.C.: National Academies Press. National Research Council. 2009a. A Survey of Attitudes and Actions on Dual Use Research in the Life Sciences: A Collaborative Effort of the National Research Council and the American Association for the Advancement of Science. Washington, D.C.: National Academies Press. National Research Council. 2009b. Countering Biological Threats: Challenges for the Department of Defense's Nonproliferation Program Beyond the Former Soviet Union. Washington, D. C.: National Academies Press. National Research Council. 2009c. Global Security Engagement: A New Model for Cooperative Threat Reduction. Washington, D.C.: National Academies Press. National Research Council. 2009d. The 2nd International Forum on Biosecurity: Summary of an International Meeting, Budapest, Hungary, March 30 to April 2, 2008. Washington, D.C.: National Academies Press. National Research Council. 2009e. Responsible Research with Biological Select Agents and Toxins. Washington, D.C.: National Academies Press. National Research Council. 2010a. Infectious Disease Movement in a Borderless World: Workshop Summary. Washington, D.C.: National Academies Press. National Research Council. 2010b. Evaluation of the Health and Safety Risks of the New USAMRIID High-containment Facilities at Fort Detrick, Maryland. Washington, D.C.:. National Academies Press. National Research Council. 2010c. Evaluation of a Site-Specific Risk Assessment for the Department of Homeland Security's Planned National Bio- and Agro-Defense Facility in Manhattan, Kansas. Washington, D.C.: National Academies Press. National Research Council. 2010d. Challenges and Opportunities for Education About Dual Use Issues in the Life Sciences. Washington, D.C.: National Academies Press. National Research Council. 2011a. Review of the Scientific Approaches Used During the FBI's Investigation of the 2001 Anthrax Letters. Washington, D. C. :National Academies Press. National Research Council. 2011b. Trends in Science and Technology Relevant to the Biological and Toxin Weapons Convention: Summary of an International Workshop: October 31 to November 3, 2010, Beijing, China. Washington, D. C.: National Academies Press. National Research Council. 2011c. Protecting the Frontline in Biodefense Research: The Special Immunizations Program. Washington, D.C.: National Academies Press. Picard-Meyer, E., J. Barrat, and F. Cliquet. 2007. Use of filter paper (FTA) technology for sampling, recovery and molecular characterisation of rabies viruses. Journal of Virological Methods 140(1- 2):174-182. Pike, R.M. 1979. Laboratory-associated infections: incidence, fatalities, causes, and prevention. Annual Review of Microbiology 33:41-66. Public Law 104-132: Antiterrorism and Effective Death Penalty Act of 1996. (110 Stat. 1214, 04/24/1996). [Online]. Available: http://www.gpo.gov/fdsys/pkg/PLAW-104publ132/pdf/PLAW-104publ132.pdf. Public Law 107-56: Uniting and Strengthening America by Providing Appropriate Tools Required to Intercept and Obstruct Terrorism (USA Patriot Act) Act of 2001. (115 Stat. 272, 10/26/2001). [Online]. Available at: http://frwebgate.access.gpo.gov/cgi- bin/getdoc.cgi?dbname=107_cong_public_laws&docid=f:publ056.107.pdf. Public Law 107-188: Public Health Security and Bioterrorism Preparedness and Response Act of 2002. (116 Stat. 594, 06/12/2002). [Online]. Available: http://www.epa.gov/watersecurity/pubs/security_act.pdf. Rusnak, J.M., M.G. Kortepter, R.J. Hawley, A.O., Anderson, E. Boudreau, and E. Eitzen. 2004. Risk of occupationally acquired illness from biological threat agents in unvaccinated laboratory workers. Biosecurity and Bioterrorism: Biodefense Strategy, Practice, and Science 2(4):281-293.

OCR for page 97
99 References Sawyer, J., A. Bennett, V. Haines, E. Elton, K. Crago, S. Speight. 2006. Measuring the loss of dexterity during microbiological containment systems use. Journal of Occupational and Environmental Hygiene 4(3):166-173. Shi, Y., Y. Yi, P. Li, T. Kuang, L. Li, M. Dong, Q. Ma, C. Cao. 2003. Diagnosis of severe acute respiratory syndrome (SARS) by detection of SARS coronavirus nucleocapsid antibodies in an antigen- capturing enzyme-linked immunosorbent assay. Journal of Clinical Microbiology 41(12):5781- 5782. Schwarz, T.F., H. Nsanze, M. Longson, H. Nitschko, S. Gilch, H. Shurie, A. Ameen, A.R. Zahir, U.G. Acharya, and G. Jager. 1996. Polymerase chain reaction for diagnosis and identification of distinct variants of Crimean-Congo hemorrhagic fever virus in the United Arab Emirates. The American Journal of Tropical Medicine and Hygiene 55(2):190-196. Stavskiy, E.A., B. Johnson, R.J. Hawley, J.T. Crane, N.B. Cherny, I.V. Renau, and S.V. Netesov. 2003. Comparative Analysis of Biosafety Guidelines of the USA, WHO, and Russia (Organizational and Controlling, Medical and Sanitary- Antiepidemiological Aspects). Applied Biosafety 8(3):118-127. Tumpey, T.M., C.F. Basler, P.V. Aguilar, H. Zeng, A. Solórzano, D.E. Swayne, N.J. Cox, J.M. Katz, J.K. Taubenberger, P. Palese, and A. García-Sastre. 2005. Characterization of the reconstructed 1918 Spanish influenza pandemic virus. Science 310(5745):77-80. Uganda National Academy of Science (UNAS). 2008. Promoting Biosafety and Biosecurity Within the Life Sciences: An International Workshop in East Africa. Uganda National Academy of Sciences, Kampala, Uganda. Uganda National Academy of Science. 2009. Establishing and Promoting Standards and Good Laboratory Practice (GLP) for Running Safe, Secure, and Sustainable Laboratories in Africa. Uganda National Academy of Sciences. Kampala, Uganda: Uganda National Academy of Sciences. 2010. Scope of Biosafety and Biosecurity in Uganda: Policy Recommendations for the Control of Associated Risks: A Consensus Study Report. Uganda National Academy of Sciences, Kampala, Uganda. United Nations (U.N.) Security Council, 4956th Meeting. 2004. Resolution 1540. (S/RES/1540). April 28, 2004. United States Department of Health and Human Services (United States HHS). 2009. Biosafety in Microbiological and Biomedical Laboratories. 5th Edition. HHS Publication No. (CDC) 21-1112. Washington, D.C. 438 pp. [Online]. Available: http://www.cdc.gov/biosafety/publications/bmbl5/BMBL.pdf. United States Government Accountability Office (United States GAO). 2007. High-Containment Biosafety Laboratories: Preliminary Observations on the Oversight of the Proliferation of BSL-3 and BSL-4 Laboratories in the United States. GAO-08-108T. Washington, D.C. [Online]. Available: http://www.gao.gov/new.items/d08108t.pdf. United States Government Accountability Office. 2009. High-Containment Laboratories: National Strategy for Oversight Is Needed. Report to Congressional Requesters. GAO-09-574. Washington, D.C. [Online]. Available: http://www.gao.gov/new.items/d09574.pdf. van de Wal, B.W., J.R. Joubert, P.J. van Eeden, and J.B. King. 1985. A nosocomial outbreak of Crimean- Congo haemorrhagic fever at Tygerberg Hospital. Part IV. Preventive and prophylactic measures. South African Medical Journal 68(10):729-732. Wacharapluesadee, S. and T. Hemachudha. 2007. Duplex nested RT-PCR for detection of Nipah virus RNA from urine specimens of bats. Journal of Virological Methods 141(1):97-101. Wacharapluesadee, S., P. Phumesin, B. Lumlertdaecha, and T. Hemachudha. 2003. Diagnosis of rabies by use of brain tissue dried on filter paper. Clinical Infectious Diseases 36(5):674-675. World Health Organization (WHO). 2004. Laboratory Biosafety Manual. 3rd Edition. WHO Press, Geneva, Switzerland. 178 pp. World Health Organization. 2005. Enhancement of Laboratory Biosafety. World Health Assembly resolution WHA58.29. World Health Organization, Geneva, Switzerland. [Online]. Available: www.who.int/gb/ebwha/pdf_files/WHA58/WHA58_29-en.pdf. World Health Organization. 2008. International Health Regulations 2005. 2nd Edition. Geneva, Switzerland WHO Press. 74 pp.

OCR for page 97